DE69230163T2 - Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten - Google Patents
Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthaltenInfo
- Publication number
- DE69230163T2 DE69230163T2 DE69230163T DE69230163T DE69230163T2 DE 69230163 T2 DE69230163 T2 DE 69230163T2 DE 69230163 T DE69230163 T DE 69230163T DE 69230163 T DE69230163 T DE 69230163T DE 69230163 T2 DE69230163 T2 DE 69230163T2
- Authority
- DE
- Germany
- Prior art keywords
- alkyl
- compound
- salt
- formula
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 238000000034 method Methods 0.000 title claims abstract description 109
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 5
- 238000002360 preparation method Methods 0.000 title abstract description 24
- IQDNFLQNJPENQU-UHFFFAOYSA-N 2-(1-benzofuran-2-yl)-1,3-thiazole Chemical class C1=CSC(C=2OC3=CC=CC=C3C=2)=N1 IQDNFLQNJPENQU-UHFFFAOYSA-N 0.000 title description 7
- 150000001875 compounds Chemical class 0.000 claims abstract description 320
- 150000003839 salts Chemical class 0.000 claims abstract description 239
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 122
- -1 cyano, hydroxy Chemical group 0.000 claims abstract description 112
- 125000003118 aryl group Chemical group 0.000 claims abstract description 90
- 125000002252 acyl group Chemical group 0.000 claims abstract description 84
- 125000000623 heterocyclic group Chemical group 0.000 claims abstract description 64
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 45
- 150000002367 halogens Chemical group 0.000 claims abstract description 45
- 125000004093 cyano group Chemical group *C#N 0.000 claims abstract description 40
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 25
- 239000001257 hydrogen Substances 0.000 claims abstract description 25
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract description 20
- 125000005843 halogen group Chemical group 0.000 claims abstract description 18
- 125000005279 aryl sulfonyloxy group Chemical group 0.000 claims abstract description 15
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims abstract description 14
- 229910052717 sulfur Inorganic materials 0.000 claims abstract description 14
- 125000004429 atom Chemical group 0.000 claims abstract description 10
- 125000001424 substituent group Chemical group 0.000 claims abstract description 10
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000000203 mixture Substances 0.000 claims description 116
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims description 105
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims description 69
- 239000002253 acid Substances 0.000 claims description 43
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 19
- 125000003831 tetrazolyl group Chemical group 0.000 claims description 17
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 15
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 14
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims description 8
- 125000006517 heterocyclyl carbonyl group Chemical group 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 150000001412 amines Chemical class 0.000 claims description 7
- 238000010531 catalytic reduction reaction Methods 0.000 claims description 7
- 239000003638 chemical reducing agent Substances 0.000 claims description 7
- 230000002265 prevention Effects 0.000 claims description 6
- SCEIUGQQBYRBPP-UHFFFAOYSA-N 2,3,4,5-tetrahydro-1h-azepine Chemical compound C1CCC=CNC1 SCEIUGQQBYRBPP-UHFFFAOYSA-N 0.000 claims description 5
- 125000005115 alkyl carbamoyl group Chemical group 0.000 claims description 5
- 125000003435 aroyl group Chemical group 0.000 claims description 5
- 206010020751 Hypersensitivity Diseases 0.000 claims description 4
- 206010061218 Inflammation Diseases 0.000 claims description 4
- 150000001356 alkyl thiols Chemical class 0.000 claims description 4
- 230000007815 allergy Effects 0.000 claims description 4
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims description 4
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 4
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 claims description 4
- 239000012024 dehydrating agents Substances 0.000 claims description 4
- 230000004054 inflammatory process Effects 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 125000001038 naphthoyl group Chemical group C1(=CC=CC2=CC=CC=C12)C(=O)* 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 4
- 239000007800 oxidant agent Substances 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 125000004076 pyridyl group Chemical group 0.000 claims description 4
- 238000007363 ring formation reaction Methods 0.000 claims description 4
- 125000001544 thienyl group Chemical group 0.000 claims description 4
- 125000005425 toluyl group Chemical group 0.000 claims description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 4
- QALVWRPQKALRFR-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=N1 QALVWRPQKALRFR-UHFFFAOYSA-N 0.000 claims description 3
- 241001465754 Metazoa Species 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 3
- 125000005073 adamantyl group Chemical group C12(CC3CC(CC(C1)C3)C2)* 0.000 claims description 3
- 150000003973 alkyl amines Chemical class 0.000 claims description 3
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims description 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims description 3
- 230000002140 halogenating effect Effects 0.000 claims description 3
- 231100000252 nontoxic Toxicity 0.000 claims description 3
- 230000003000 nontoxic effect Effects 0.000 claims description 3
- 159000000000 sodium salts Chemical class 0.000 claims description 3
- PSILZZNMGXTOOP-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC(O)=O)C=C3C=2)=N1 PSILZZNMGXTOOP-UHFFFAOYSA-N 0.000 claims description 2
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 claims description 2
- 238000005917 acylation reaction Methods 0.000 claims description 2
- 125000002057 carboxymethyl group Chemical group [H]OC(=O)C([H])([H])[*] 0.000 claims description 2
- 238000006900 dealkylation reaction Methods 0.000 claims description 2
- 238000007257 deesterification reaction Methods 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 125000004970 halomethyl group Chemical group 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 230000001225 therapeutic effect Effects 0.000 claims description 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 claims 15
- 125000005862 (C1-C6)alkanoyl group Chemical group 0.000 claims 6
- 125000005947 C1-C6 alkylsulfonyloxy group Chemical group 0.000 claims 6
- 125000003161 (C1-C6) alkylene group Chemical group 0.000 claims 5
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 claims 4
- 125000004890 (C1-C6) alkylamino group Chemical group 0.000 claims 4
- 125000004739 (C1-C6) alkylsulfonyl group Chemical group 0.000 claims 4
- 125000006590 (C2-C6) alkenylene group Chemical group 0.000 claims 4
- 125000004454 (C1-C6) alkoxycarbonyl group Chemical group 0.000 claims 3
- 125000004738 (C1-C6) alkyl sulfinyl group Chemical group 0.000 claims 3
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 3
- 125000000596 cyclohexenyl group Chemical group C1(=CCCCC1)* 0.000 claims 2
- 150000001335 aliphatic alkanes Chemical group 0.000 claims 1
- 150000004684 trihydrates Chemical class 0.000 claims 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract description 25
- 125000003545 alkoxy group Chemical group 0.000 abstract description 7
- 125000003282 alkyl amino group Chemical group 0.000 abstract description 6
- 125000004644 alkyl sulfinyl group Chemical group 0.000 abstract description 6
- 125000005278 alkyl sulfonyloxy group Chemical group 0.000 abstract description 6
- 125000003342 alkenyl group Chemical group 0.000 abstract description 5
- 125000004450 alkenylene group Chemical group 0.000 abstract description 5
- 125000002947 alkylene group Chemical group 0.000 abstract description 5
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 229910052727 yttrium Inorganic materials 0.000 abstract 1
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 198
- 238000006243 chemical reaction Methods 0.000 description 176
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 111
- 238000002844 melting Methods 0.000 description 84
- 230000008018 melting Effects 0.000 description 84
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 81
- 239000002585 base Substances 0.000 description 69
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 62
- 239000002904 solvent Substances 0.000 description 56
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 55
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 54
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 50
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 46
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 45
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
- 238000001816 cooling Methods 0.000 description 40
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 38
- 239000000243 solution Substances 0.000 description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 35
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 30
- 238000001914 filtration Methods 0.000 description 25
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 25
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 24
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 24
- 230000002411 adverse Effects 0.000 description 24
- 239000012267 brine Substances 0.000 description 23
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 23
- 235000019341 magnesium sulphate Nutrition 0.000 description 23
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 23
- 239000006188 syrup Substances 0.000 description 23
- 235000020357 syrup Nutrition 0.000 description 23
- 238000010792 warming Methods 0.000 description 21
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 20
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 19
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 18
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 18
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 18
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 229910052783 alkali metal Inorganic materials 0.000 description 18
- 238000004440 column chromatography Methods 0.000 description 18
- 239000012044 organic layer Substances 0.000 description 18
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 18
- 239000000741 silica gel Substances 0.000 description 18
- 229910002027 silica gel Inorganic materials 0.000 description 18
- 238000003756 stirring Methods 0.000 description 18
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 17
- 239000002244 precipitate Substances 0.000 description 17
- 239000003054 catalyst Substances 0.000 description 16
- 238000010992 reflux Methods 0.000 description 16
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- 239000005457 ice water Substances 0.000 description 15
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 14
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 229910052751 metal Inorganic materials 0.000 description 14
- 239000002184 metal Substances 0.000 description 14
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 239000003960 organic solvent Substances 0.000 description 12
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 12
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 10
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 10
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 10
- 238000006722 reduction reaction Methods 0.000 description 10
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 10
- 150000001342 alkaline earth metals Chemical class 0.000 description 9
- 239000013078 crystal Substances 0.000 description 9
- GQHTUMJGOHRCHB-UHFFFAOYSA-N 2,3,4,6,7,8,9,10-octahydropyrimido[1,2-a]azepine Chemical compound C1CCCCN2CCCN=C21 GQHTUMJGOHRCHB-UHFFFAOYSA-N 0.000 description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 8
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 229910052697 platinum Inorganic materials 0.000 description 8
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 7
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 150000001340 alkali metals Chemical class 0.000 description 7
- 238000000354 decomposition reaction Methods 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- 239000008096 xylene Substances 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 6
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 description 6
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 6
- WQDUMFSSJAZKTM-UHFFFAOYSA-N Sodium methoxide Chemical compound [Na+].[O-]C WQDUMFSSJAZKTM-UHFFFAOYSA-N 0.000 description 6
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 6
- 235000011054 acetic acid Nutrition 0.000 description 6
- ILAHWRKJUDSMFH-UHFFFAOYSA-N boron tribromide Chemical compound BrB(Br)Br ILAHWRKJUDSMFH-UHFFFAOYSA-N 0.000 description 6
- 229910017052 cobalt Inorganic materials 0.000 description 6
- 239000010941 cobalt Substances 0.000 description 6
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 6
- 229910052802 copper Inorganic materials 0.000 description 6
- 239000010949 copper Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052763 palladium Inorganic materials 0.000 description 6
- 239000012312 sodium hydride Substances 0.000 description 6
- 229910000104 sodium hydride Inorganic materials 0.000 description 6
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 6
- YXRUWYWSPZHKLD-UHFFFAOYSA-N 2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-carbaldehyde Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(C=O)C=C3C=2)=N1 YXRUWYWSPZHKLD-UHFFFAOYSA-N 0.000 description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 5
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 5
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 5
- FZWLAAWBMGSTSO-UHFFFAOYSA-N Thiazole Chemical compound C1=CSC=N1 FZWLAAWBMGSTSO-UHFFFAOYSA-N 0.000 description 5
- 150000008065 acid anhydrides Chemical class 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 125000001589 carboacyl group Chemical group 0.000 description 5
- 238000006757 chemical reactions by type Methods 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 5
- 239000011777 magnesium Substances 0.000 description 5
- 229910052749 magnesium Inorganic materials 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 150000007524 organic acids Chemical class 0.000 description 5
- 239000011591 potassium Substances 0.000 description 5
- 229910052700 potassium Inorganic materials 0.000 description 5
- 239000011541 reaction mixture Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- 235000009518 sodium iodide Nutrition 0.000 description 5
- BNALANGFESRXOP-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 BNALANGFESRXOP-UHFFFAOYSA-N 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 4
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 4
- CSDQQAQKBAQLLE-UHFFFAOYSA-N 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine Chemical compound C1=CC(Cl)=CC=C1C1C(C=CS2)=C2CCN1 CSDQQAQKBAQLLE-UHFFFAOYSA-N 0.000 description 4
- PNZYQVLBRDFJLB-UHFFFAOYSA-N 4-tert-butyl-2-[5-(chloromethyl)-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CCl)C=C3C=2)=N1 PNZYQVLBRDFJLB-UHFFFAOYSA-N 0.000 description 4
- FZHSPPYCNDYIKD-UHFFFAOYSA-N 5-methoxysalicylaldehyde Chemical compound COC1=CC=C(O)C(C=O)=C1 FZHSPPYCNDYIKD-UHFFFAOYSA-N 0.000 description 4
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 4
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- PXIPVTKHYLBLMZ-UHFFFAOYSA-N Sodium azide Chemical compound [Na+].[N-]=[N+]=[N-] PXIPVTKHYLBLMZ-UHFFFAOYSA-N 0.000 description 4
- 229910000102 alkali metal hydride Inorganic materials 0.000 description 4
- 150000008046 alkali metal hydrides Chemical class 0.000 description 4
- 229910001516 alkali metal iodide Inorganic materials 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 229910052744 lithium Inorganic materials 0.000 description 4
- ZCSHNCUQKCANBX-UHFFFAOYSA-N lithium diisopropylamide Chemical compound [Li+].CC(C)[N-]C(C)C ZCSHNCUQKCANBX-UHFFFAOYSA-N 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- 150000007522 mineralic acids Chemical class 0.000 description 4
- 229910052759 nickel Inorganic materials 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 229910000027 potassium carbonate Inorganic materials 0.000 description 4
- 235000011181 potassium carbonates Nutrition 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- SGUVLZREKBPKCE-UHFFFAOYSA-N 1,5-diazabicyclo[4.3.0]-non-5-ene Chemical compound C1CCN=C2CCCN21 SGUVLZREKBPKCE-UHFFFAOYSA-N 0.000 description 3
- FWSXVUZYZVPTIF-UHFFFAOYSA-N 2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 FWSXVUZYZVPTIF-UHFFFAOYSA-N 0.000 description 3
- YCMLQMDWSXFTIF-UHFFFAOYSA-N 2-methylbenzenesulfonimidic acid Chemical compound CC1=CC=CC=C1S(N)(=O)=O YCMLQMDWSXFTIF-UHFFFAOYSA-N 0.000 description 3
- BSKHPKMHTQYZBB-UHFFFAOYSA-N 2-methylpyridine Chemical compound CC1=CC=CC=N1 BSKHPKMHTQYZBB-UHFFFAOYSA-N 0.000 description 3
- ZRCORLXUHDZQNV-UHFFFAOYSA-N 4-tert-butyl-2-(5-methoxy-1-benzofuran-2-yl)-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C1=NC(C(C)(C)C)=CS1 ZRCORLXUHDZQNV-UHFFFAOYSA-N 0.000 description 3
- XBJDWSFHEMVWIV-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 XBJDWSFHEMVWIV-UHFFFAOYSA-N 0.000 description 3
- RVDLHGSZWAELAU-UHFFFAOYSA-N 5-tert-butylthiophene-2-carbonyl chloride Chemical compound CC(C)(C)C1=CC=C(C(Cl)=O)S1 RVDLHGSZWAELAU-UHFFFAOYSA-N 0.000 description 3
- 206010001052 Acute respiratory distress syndrome Diseases 0.000 description 3
- 206010002199 Anaphylactic shock Diseases 0.000 description 3
- 206010003210 Arteriosclerosis Diseases 0.000 description 3
- 206010048962 Brain oedema Diseases 0.000 description 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 3
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 3
- 208000018152 Cerebral disease Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- 208000011231 Crohn disease Diseases 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 3
- 208000007882 Gastritis Diseases 0.000 description 3
- 201000005569 Gout Diseases 0.000 description 3
- 208000022559 Inflammatory bowel disease Diseases 0.000 description 3
- 239000002841 Lewis acid Substances 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 3
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 3
- 206010033645 Pancreatitis Diseases 0.000 description 3
- 201000004681 Psoriasis Diseases 0.000 description 3
- 206010040070 Septic Shock Diseases 0.000 description 3
- 208000007107 Stomach Ulcer Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 201000000028 adult respiratory distress syndrome Diseases 0.000 description 3
- 239000005557 antagonist Substances 0.000 description 3
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 3
- 208000011775 arteriosclerosis disease Diseases 0.000 description 3
- 206010003246 arthritis Diseases 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 125000004244 benzofuran-2-yl group Chemical group [H]C1=C(*)OC2=C([H])C([H])=C([H])C([H])=C12 0.000 description 3
- 230000027455 binding Effects 0.000 description 3
- 208000006752 brain edema Diseases 0.000 description 3
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 3
- 229910052794 bromium Inorganic materials 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 3
- 229910052731 fluorine Inorganic materials 0.000 description 3
- 239000011737 fluorine Substances 0.000 description 3
- 201000005917 gastric ulcer Diseases 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 208000006454 hepatitis Diseases 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 3
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 3
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 239000003112 inhibitor Substances 0.000 description 3
- 208000001286 intracranial vasospasm Diseases 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 150000002617 leukotrienes Chemical class 0.000 description 3
- 150000007517 lewis acids Chemical class 0.000 description 3
- CRGZYKWWYNQGEC-UHFFFAOYSA-N magnesium;methanolate Chemical compound [Mg+2].[O-]C.[O-]C CRGZYKWWYNQGEC-UHFFFAOYSA-N 0.000 description 3
- 208000010125 myocardial infarction Diseases 0.000 description 3
- 201000008383 nephritis Diseases 0.000 description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 3
- 230000002685 pulmonary effect Effects 0.000 description 3
- 208000002815 pulmonary hypertension Diseases 0.000 description 3
- 206010039083 rhinitis Diseases 0.000 description 3
- 230000036303 septic shock Effects 0.000 description 3
- 230000035939 shock Effects 0.000 description 3
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- PXQLVRUNWNTZOS-UHFFFAOYSA-N sulfanyl Chemical class [SH] PXQLVRUNWNTZOS-UHFFFAOYSA-N 0.000 description 3
- 125000005270 trialkylamine group Chemical group 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- IISOIQHTJLMMLZ-UHFFFAOYSA-M (2-ethoxycarbonylphenyl)methyl-triphenylphosphanium;bromide Chemical compound [Br-].CCOC(=O)C1=CC=CC=C1C[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 IISOIQHTJLMMLZ-UHFFFAOYSA-M 0.000 description 2
- WSLDOOZREJYCGB-UHFFFAOYSA-N 1,2-Dichloroethane Chemical compound ClCCCl WSLDOOZREJYCGB-UHFFFAOYSA-N 0.000 description 2
- DZOXPAYEAYNYMA-UHFFFAOYSA-N 1-(5-methoxy-1-benzofuran-2-yl)ethanone Chemical compound COC1=CC=C2OC(C(C)=O)=CC2=C1 DZOXPAYEAYNYMA-UHFFFAOYSA-N 0.000 description 2
- VEGPSYLREWWGAU-UHFFFAOYSA-N 1-[2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-8-yl]ethanone Chemical compound N=1C=2C(C(=O)C)CCCNC=2SC=1C(OC1=CC=2)=CC1=CC=2OCC1=CC=CC=C1CC1=NN=NN1 VEGPSYLREWWGAU-UHFFFAOYSA-N 0.000 description 2
- KJUGUADJHNHALS-UHFFFAOYSA-N 1H-tetrazole Substances C=1N=NNN=1 KJUGUADJHNHALS-UHFFFAOYSA-N 0.000 description 2
- ALXDZWOFWIALGS-UHFFFAOYSA-N 2-(2-formyl-4-methoxyphenoxy)acetonitrile Chemical compound COC1=CC=C(OCC#N)C(C=O)=C1 ALXDZWOFWIALGS-UHFFFAOYSA-N 0.000 description 2
- SBASXUCJHJRPEV-UHFFFAOYSA-N 2-(2-methoxyethoxy)ethanol Chemical compound COCCOCCO SBASXUCJHJRPEV-UHFFFAOYSA-N 0.000 description 2
- TVKWECKQHNTPMG-UHFFFAOYSA-N 2-(bromomethyl)-4-tert-butyl-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(CBr)=N1 TVKWECKQHNTPMG-UHFFFAOYSA-N 0.000 description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 2
- ZRHOACSSGGJLRP-UHFFFAOYSA-N 2-[4-(chloromethyl)-1,3-thiazol-2-yl]-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C1=NC(CCl)=CS1 ZRHOACSSGGJLRP-UHFFFAOYSA-N 0.000 description 2
- MXVGTYBWKONZRD-UHFFFAOYSA-N 2-[4-[(tert-butylamino)methyl]-1,3-thiazol-2-yl]-1-benzofuran-5-ol Chemical compound CC(C)(C)NCC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 MXVGTYBWKONZRD-UHFFFAOYSA-N 0.000 description 2
- FBFBAXVUXDBYAR-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-hexyl-1,3-thiazole Chemical compound CCCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 FBFBAXVUXDBYAR-UHFFFAOYSA-N 0.000 description 2
- FUJZAGIXVDMRPZ-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methylsulfanyl]benzoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CSC=4C(=CC=CC=4)C(O)=O)C=C3C=2)=N1 FUJZAGIXVDMRPZ-UHFFFAOYSA-N 0.000 description 2
- HYEMCPMRYDUHSN-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzaldehyde Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)C=O)C=C3C=2)=N1 HYEMCPMRYDUHSN-UHFFFAOYSA-N 0.000 description 2
- UKFXZVDPWRYNQM-UHFFFAOYSA-N 2-[[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]methyl]propanedioic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC(C(O)=O)C(O)=O)C=C3C=2)=N1 UKFXZVDPWRYNQM-UHFFFAOYSA-N 0.000 description 2
- KDSNLYIMUZNERS-UHFFFAOYSA-N 2-methylpropanamine Chemical compound CC(C)CN KDSNLYIMUZNERS-UHFFFAOYSA-N 0.000 description 2
- WYKHSBAVLOPISI-UHFFFAOYSA-N 2-phenyl-1,3-thiazole Chemical compound C1=CSC(C=2C=CC=CC=2)=N1 WYKHSBAVLOPISI-UHFFFAOYSA-N 0.000 description 2
- ULRPISSMEBPJLN-UHFFFAOYSA-N 2h-tetrazol-5-amine Chemical compound NC1=NN=NN1 ULRPISSMEBPJLN-UHFFFAOYSA-N 0.000 description 2
- SITBSXWUFLOGAS-UHFFFAOYSA-N 3-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]-2,2-dimethylpropanoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CC(C)(C)C(O)=O)C=C3C=2)=N1 SITBSXWUFLOGAS-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 2
- NAASIWUJCOIUMX-UHFFFAOYSA-N 4-[(4-tert-butyl-1,3-thiazol-2-yl)methoxy]benzene-1,3-dicarbaldehyde Chemical compound CC(C)(C)C1=CSC(COC=2C(=CC(C=O)=CC=2)C=O)=N1 NAASIWUJCOIUMX-UHFFFAOYSA-N 0.000 description 2
- FEUATHOQKVGPEK-UHFFFAOYSA-N 4-hydroxybenzene-1,3-dicarbaldehyde Chemical compound OC1=CC=C(C=O)C=C1C=O FEUATHOQKVGPEK-UHFFFAOYSA-N 0.000 description 2
- QVFBRRBYYIDZOG-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(2-methylsulfanyl-2-methylsulfinylethenyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CSC(S(C)=O)=CC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 QVFBRRBYYIDZOG-UHFFFAOYSA-N 0.000 description 2
- YYROPELSRYBVMQ-UHFFFAOYSA-N 4-toluenesulfonyl chloride Chemical compound CC1=CC=C(S(Cl)(=O)=O)C=C1 YYROPELSRYBVMQ-UHFFFAOYSA-N 0.000 description 2
- UJKGHPHSZMHGPH-UHFFFAOYSA-N 5-hydroxy-1-benzofuran-2-carbothioamide Chemical compound OC1=CC=C2OC(C(=S)N)=CC2=C1 UJKGHPHSZMHGPH-UHFFFAOYSA-N 0.000 description 2
- FBZOVBYQQNIYBV-UHFFFAOYSA-N 5-methoxy-1-benzofuran-2-carbothioamide Chemical compound COC1=CC=C2OC(C(N)=S)=CC2=C1 FBZOVBYQQNIYBV-UHFFFAOYSA-N 0.000 description 2
- AOCUYPLJQNFUBI-UHFFFAOYSA-N 5-methoxy-n-(2-oxoazepan-3-yl)-1-benzofuran-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(=O)NC1CCCCNC1=O AOCUYPLJQNFUBI-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- KZMGYPLQYOPHEL-UHFFFAOYSA-N Boron trifluoride etherate Chemical compound FB(F)F.CCOCC KZMGYPLQYOPHEL-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 2
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 2
- QUSNBJAOOMFDIB-UHFFFAOYSA-N Ethylamine Chemical compound CCN QUSNBJAOOMFDIB-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- WTDHULULXKLSOZ-UHFFFAOYSA-N Hydroxylamine hydrochloride Chemical compound Cl.ON WTDHULULXKLSOZ-UHFFFAOYSA-N 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 239000012359 Methanesulfonyl chloride Substances 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 239000007868 Raney catalyst Substances 0.000 description 2
- 229910000564 Raney nickel Inorganic materials 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- BJJGPJNFIWHDQT-UHFFFAOYSA-N [2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methanol Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CO)C=C3C=2)=N1 BJJGPJNFIWHDQT-UHFFFAOYSA-N 0.000 description 2
- STYBRPVXARSAAK-UHFFFAOYSA-N [2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methylsulfanyl]phenyl]methanol Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CSC=4C(=CC=CC=4)CO)C=C3C=2)=N1 STYBRPVXARSAAK-UHFFFAOYSA-N 0.000 description 2
- 125000005907 alkyl ester group Chemical group 0.000 description 2
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 2
- 235000019270 ammonium chloride Nutrition 0.000 description 2
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 2
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 2
- NDKBVBUGCNGSJJ-UHFFFAOYSA-M benzyltrimethylammonium hydroxide Chemical compound [OH-].C[N+](C)(C)CC1=CC=CC=C1 NDKBVBUGCNGSJJ-UHFFFAOYSA-M 0.000 description 2
- WTEOIRVLGSZEPR-UHFFFAOYSA-N boron trifluoride Chemical compound FB(F)F WTEOIRVLGSZEPR-UHFFFAOYSA-N 0.000 description 2
- HQABUPZFAYXKJW-UHFFFAOYSA-N butan-1-amine Chemical compound CCCCN HQABUPZFAYXKJW-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 2
- KXZJHVJKXJLBKO-UHFFFAOYSA-N chembl1408157 Chemical compound N=1C2=CC=CC=C2C(C(=O)O)=CC=1C1=CC=C(O)C=C1 KXZJHVJKXJLBKO-UHFFFAOYSA-N 0.000 description 2
- QTMDXZNDVAMKGV-UHFFFAOYSA-L copper(ii) bromide Chemical compound [Cu+2].[Br-].[Br-] QTMDXZNDVAMKGV-UHFFFAOYSA-L 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 150000001925 cycloalkenes Chemical group 0.000 description 2
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cyclohexene Chemical compound C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 2
- JQVDAXLFBXTEQA-UHFFFAOYSA-N dibutylamine Chemical compound CCCCNCCCC JQVDAXLFBXTEQA-UHFFFAOYSA-N 0.000 description 2
- KGTWUQFETIEFKI-UHFFFAOYSA-N diethyl 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methyl]propanedioate Chemical compound C=1C2=CC(CC(C(=O)OCC)C(=O)OCC)=CC=C2OC=1C1=NC(C(C)(C)C)=CS1 KGTWUQFETIEFKI-UHFFFAOYSA-N 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- JZRYZNCFHHWXLT-UHFFFAOYSA-N ethyl 2-[2-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]ethenyl]benzoate Chemical compound CCOC(=O)C1=CC=CC=C1C=CC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 JZRYZNCFHHWXLT-UHFFFAOYSA-N 0.000 description 2
- GUWLSZDZWACRBS-UHFFFAOYSA-N ethyl 2-[2-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]ethyl]benzoate Chemical compound CCOC(=O)C1=CC=CC=C1CCC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 GUWLSZDZWACRBS-UHFFFAOYSA-N 0.000 description 2
- RIFGWPKJUGCATF-UHFFFAOYSA-N ethyl chloroformate Chemical compound CCOC(Cl)=O RIFGWPKJUGCATF-UHFFFAOYSA-N 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- 229940071870 hydroiodic acid Drugs 0.000 description 2
- 150000007529 inorganic bases Chemical class 0.000 description 2
- 239000002198 insoluble material Substances 0.000 description 2
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 239000012280 lithium aluminium hydride Substances 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- QARBMVPHQWIHKH-UHFFFAOYSA-N methanesulfonyl chloride Chemical compound CS(Cl)(=O)=O QARBMVPHQWIHKH-UHFFFAOYSA-N 0.000 description 2
- RIFFHFIDKGXZAS-UHFFFAOYSA-N methyl 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzoate Chemical compound COC(=O)C1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 RIFFHFIDKGXZAS-UHFFFAOYSA-N 0.000 description 2
- NHGZEJHJHUHZDI-UHFFFAOYSA-N methyl 2-sulfanylbutanoate Chemical compound CCC(S)C(=O)OC NHGZEJHJHUHZDI-UHFFFAOYSA-N 0.000 description 2
- JIXPEHBNFXLJEI-UHFFFAOYSA-N methyl 3-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]-2,2-dimethylpropanoate Chemical compound C=1C2=CC(CC(C)(C)C(=O)OC)=CC=C2OC=1C1=NC(C(C)(C)C)=CS1 JIXPEHBNFXLJEI-UHFFFAOYSA-N 0.000 description 2
- KFBDRZJNGWQOMM-UHFFFAOYSA-N methyl 4-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylbutanoate Chemical compound C=1C2=CC(C(SCCC(=O)N(C)C)SCCCC(=O)OC)=CC=C2OC=1C1=NC(C(C)(C)C)=CS1 KFBDRZJNGWQOMM-UHFFFAOYSA-N 0.000 description 2
- BHIWKHZACMWKOJ-UHFFFAOYSA-N methyl isobutyrate Chemical compound COC(=O)C(C)C BHIWKHZACMWKOJ-UHFFFAOYSA-N 0.000 description 2
- XKBGEWXEAPTVCK-UHFFFAOYSA-M methyltrioctylammonium chloride Chemical compound [Cl-].CCCCCCCC[N+](C)(CCCCCCCC)CCCCCCCC XKBGEWXEAPTVCK-UHFFFAOYSA-M 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 235000010446 mineral oil Nutrition 0.000 description 2
- 229910000480 nickel oxide Inorganic materials 0.000 description 2
- 150000007530 organic bases Chemical class 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- GNRSAWUEBMWBQH-UHFFFAOYSA-N oxonickel Chemical compound [Ni]=O GNRSAWUEBMWBQH-UHFFFAOYSA-N 0.000 description 2
- HBEQXAKJSGXAIQ-UHFFFAOYSA-N oxopalladium Chemical compound [Pd]=O HBEQXAKJSGXAIQ-UHFFFAOYSA-N 0.000 description 2
- MUMZUERVLWJKNR-UHFFFAOYSA-N oxoplatinum Chemical compound [Pt]=O MUMZUERVLWJKNR-UHFFFAOYSA-N 0.000 description 2
- 229910003445 palladium oxide Inorganic materials 0.000 description 2
- DPBLXKKOBLCELK-UHFFFAOYSA-N pentan-1-amine Chemical compound CCCCCN DPBLXKKOBLCELK-UHFFFAOYSA-N 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 239000003444 phase transfer catalyst Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 2
- CYQAYERJWZKYML-UHFFFAOYSA-N phosphorus pentasulfide Chemical compound S1P(S2)(=S)SP3(=S)SP1(=S)SP2(=S)S3 CYQAYERJWZKYML-UHFFFAOYSA-N 0.000 description 2
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 2
- 229910003446 platinum oxide Inorganic materials 0.000 description 2
- NNFCIKHAZHQZJG-UHFFFAOYSA-N potassium cyanide Chemical compound [K+].N#[C-] NNFCIKHAZHQZJG-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical compound CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 102000005962 receptors Human genes 0.000 description 2
- 108020003175 receptors Proteins 0.000 description 2
- 239000012279 sodium borohydride Substances 0.000 description 2
- 229910000033 sodium borohydride Inorganic materials 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- HYHCSLBZRBJJCH-UHFFFAOYSA-M sodium hydrosulfide Chemical compound [Na+].[SH-] HYHCSLBZRBJJCH-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- YBRBMKDOPFTVDT-UHFFFAOYSA-N tert-butylamine Chemical compound CC(C)(C)N YBRBMKDOPFTVDT-UHFFFAOYSA-N 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- CWERGRDVMFNCDR-UHFFFAOYSA-N thioglycolic acid Chemical compound OC(=O)CS CWERGRDVMFNCDR-UHFFFAOYSA-N 0.000 description 2
- NBOMNTLFRHMDEZ-UHFFFAOYSA-N thiosalicylic acid Chemical compound OC(=O)C1=CC=CC=C1S NBOMNTLFRHMDEZ-UHFFFAOYSA-N 0.000 description 2
- 229940103494 thiosalicylic acid Drugs 0.000 description 2
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 2
- 125000003944 tolyl group Chemical group 0.000 description 2
- FAQYAMRNWDIXMY-UHFFFAOYSA-N trichloroborane Chemical compound ClB(Cl)Cl FAQYAMRNWDIXMY-UHFFFAOYSA-N 0.000 description 2
- IMNIMPAHZVJRPE-UHFFFAOYSA-N triethylenediamine Chemical compound C1CN2CCN1CC2 IMNIMPAHZVJRPE-UHFFFAOYSA-N 0.000 description 2
- CSRZQMIRAZTJOY-UHFFFAOYSA-N trimethylsilyl iodide Chemical compound C[Si](C)(C)I CSRZQMIRAZTJOY-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- VGRXAHXMIDCTNV-UHFFFAOYSA-N (6-chlorobenzotriazol-1-yl) 4-chlorobenzenesulfonate Chemical compound C1=CC(Cl)=CC=C1S(=O)(=O)ON1C2=CC(Cl)=CC=C2N=N1 VGRXAHXMIDCTNV-UHFFFAOYSA-N 0.000 description 1
- FTTATHOUSOIFOQ-UHFFFAOYSA-N 1,2,3,4,6,7,8,8a-octahydropyrrolo[1,2-a]pyrazine Chemical compound C1NCCN2CCCC21 FTTATHOUSOIFOQ-UHFFFAOYSA-N 0.000 description 1
- FMGGHNGKHRCJLL-UHFFFAOYSA-N 1,2-bis(chloromethyl)benzene Chemical group ClCC1=CC=CC=C1CCl FMGGHNGKHRCJLL-UHFFFAOYSA-N 0.000 description 1
- QUKGLNCXGVWCJX-UHFFFAOYSA-N 1,3,4-thiadiazol-2-amine Chemical compound NC1=NN=CS1 QUKGLNCXGVWCJX-UHFFFAOYSA-N 0.000 description 1
- RAIPHJJURHTUIC-UHFFFAOYSA-N 1,3-thiazol-2-amine Chemical compound NC1=NC=CS1 RAIPHJJURHTUIC-UHFFFAOYSA-N 0.000 description 1
- ORECNKBJIMKZNX-UHFFFAOYSA-N 1,3-thiazol-3-ium;chloride Chemical compound Cl.C1=CSC=N1 ORECNKBJIMKZNX-UHFFFAOYSA-N 0.000 description 1
- QFBZMBRHUZAPTL-UHFFFAOYSA-N 1-[2-(5-hydroxy-1-benzofuran-2-yl)-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-8-yl]ethanone Chemical compound CC(=O)C1CCCNC2=C1N=C(C=1OC3=CC=C(O)C=C3C=1)S2 QFBZMBRHUZAPTL-UHFFFAOYSA-N 0.000 description 1
- WETPCDNVPGRKGT-UHFFFAOYSA-N 1-[2-(5-methoxy-1-benzofuran-2-yl)-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-8-yl]ethanone Chemical compound CC(=O)C1CCCNC(S2)=C1N=C2C1=CC2=CC(OC)=CC=C2O1 WETPCDNVPGRKGT-UHFFFAOYSA-N 0.000 description 1
- XDIMOQRDIWMRMA-UHFFFAOYSA-N 1-[2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-8-yl]ethanone Chemical compound N=1C=2C(C(=O)C)CCCNC=2SC=1C(OC1=CC=2)=CC1=CC=2OCC1=CC=CC=C1CCl XDIMOQRDIWMRMA-UHFFFAOYSA-N 0.000 description 1
- SAIRZMWXVJEBMO-UHFFFAOYSA-N 1-bromo-3,3-dimethylbutan-2-one Chemical compound CC(C)(C)C(=O)CBr SAIRZMWXVJEBMO-UHFFFAOYSA-N 0.000 description 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 description 1
- BMVXCPBXGZKUPN-UHFFFAOYSA-N 1-hexanamine Chemical compound CCCCCCN BMVXCPBXGZKUPN-UHFFFAOYSA-N 0.000 description 1
- OALRKTRDVLNQAZ-UHFFFAOYSA-N 1-methylsulfinyl-1-(1-methylsulfinylethylsulfanyl)ethane Chemical compound CS(=O)C(C)SC(C)S(C)=O OALRKTRDVLNQAZ-UHFFFAOYSA-N 0.000 description 1
- LTMRRSWNXVJMBA-UHFFFAOYSA-L 2,2-diethylpropanedioate Chemical compound CCC(CC)(C([O-])=O)C([O-])=O LTMRRSWNXVJMBA-UHFFFAOYSA-L 0.000 description 1
- YQTCQNIPQMJNTI-UHFFFAOYSA-N 2,2-dimethylpropan-1-one Chemical group CC(C)(C)[C]=O YQTCQNIPQMJNTI-UHFFFAOYSA-N 0.000 description 1
- JUWKMCGQHYTQFD-UHFFFAOYSA-N 2-(2-tert-butyl-1,3-thiazol-4-yl)-1-benzofuran-5-ol;hydrobromide Chemical compound Br.S1C(C(C)(C)C)=NC(C=2OC3=CC=C(O)C=C3C=2)=C1 JUWKMCGQHYTQFD-UHFFFAOYSA-N 0.000 description 1
- MPTPXOLRFZGVTJ-UHFFFAOYSA-N 2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1-benzofuran-5-ol Chemical compound C1CCCC(S2)=C1N=C2C1=CC2=CC(O)=CC=C2O1 MPTPXOLRFZGVTJ-UHFFFAOYSA-N 0.000 description 1
- LEOOZBXZXBAGPV-UHFFFAOYSA-N 2-(4-cyclobutyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C(SC=1)=NC=1C1CCC1 LEOOZBXZXBAGPV-UHFFFAOYSA-N 0.000 description 1
- ULLAJCTYXSYOJE-UHFFFAOYSA-N 2-(4-cyclopropyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C(SC=1)=NC=1C1CC1 ULLAJCTYXSYOJE-UHFFFAOYSA-N 0.000 description 1
- SURHWKHAMWEMFC-UHFFFAOYSA-N 2-(4-hexyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound CCCCCCC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 SURHWKHAMWEMFC-UHFFFAOYSA-N 0.000 description 1
- NYCMSJGLAGXYMI-UHFFFAOYSA-N 2-(4-methyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound CC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 NYCMSJGLAGXYMI-UHFFFAOYSA-N 0.000 description 1
- CYHZWHGCYXJNBY-UHFFFAOYSA-N 2-(4-pentyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound CCCCCC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 CYHZWHGCYXJNBY-UHFFFAOYSA-N 0.000 description 1
- PNMZNPODRHJKAM-UHFFFAOYSA-N 2-(4-phenyl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CC=C1 PNMZNPODRHJKAM-UHFFFAOYSA-N 0.000 description 1
- DKUMTQAFQWGIOS-UHFFFAOYSA-N 2-(4-propan-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound CC(C)C1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 DKUMTQAFQWGIOS-UHFFFAOYSA-N 0.000 description 1
- MHUONAQKQYQPRK-UHFFFAOYSA-N 2-(4-pyridin-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CC=N1 MHUONAQKQYQPRK-UHFFFAOYSA-N 0.000 description 1
- JWFAFFDCJOYKOB-UHFFFAOYSA-N 2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-carbonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(C=C3C=2)C#N)=N1 JWFAFFDCJOYKOB-UHFFFAOYSA-N 0.000 description 1
- KNIQSVWAUDKCRS-UHFFFAOYSA-N 2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzothiophen-5-ol Chemical compound CC(C)(C)C1=CSC(C=2SC3=CC=C(O)C=C3C=2)=N1 KNIQSVWAUDKCRS-UHFFFAOYSA-N 0.000 description 1
- YIEGKCBHMGMNOJ-UHFFFAOYSA-N 2-(4-thiophen-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CS1 YIEGKCBHMGMNOJ-UHFFFAOYSA-N 0.000 description 1
- DLRJHYZDVVCTJO-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4,5,6,7-tetrahydro-1,3-benzothiazole Chemical compound C1CCCC(S2)=C1N=C2C1=CC2=CC(OC)=CC=C2O1 DLRJHYZDVVCTJO-UHFFFAOYSA-N 0.000 description 1
- APSMNLZTBGAVBJ-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4-(trifluoromethyl)-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C1=NC(C(F)(F)F)=CS1 APSMNLZTBGAVBJ-UHFFFAOYSA-N 0.000 description 1
- BUTGBZVYCCYLJH-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4-methyl-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C1=NC(C)=CS1 BUTGBZVYCCYLJH-UHFFFAOYSA-N 0.000 description 1
- XHGVFWKEBVRDJW-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4-phenyl-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CC=C1 XHGVFWKEBVRDJW-UHFFFAOYSA-N 0.000 description 1
- JNOZIOSZZAJZHB-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4-pyridin-2-yl-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CC=N1 JNOZIOSZZAJZHB-UHFFFAOYSA-N 0.000 description 1
- LBNYDHGKJUFPFJ-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-4-thiophen-2-yl-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(SC=1)=NC=1C1=CC=CS1 LBNYDHGKJUFPFJ-UHFFFAOYSA-N 0.000 description 1
- YYYKDMKXQUNELW-UHFFFAOYSA-N 2-(5-methoxy-1-benzofuran-2-yl)-5-propan-2-yl-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C1=NC=C(C(C)C)S1 YYYKDMKXQUNELW-UHFFFAOYSA-N 0.000 description 1
- LFPWYVUYVPRGBQ-UHFFFAOYSA-N 2-(5-propan-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-ol Chemical compound S1C(C(C)C)=CN=C1C1=CC2=CC(O)=CC=C2O1 LFPWYVUYVPRGBQ-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-N 2-Methylbenzenesulfonic acid Chemical compound CC1=CC=CC=C1S(O)(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-N 0.000 description 1
- LPDVAZUHYLUBSO-UHFFFAOYSA-N 2-[(4-tert-butyl-1,3-thiazol-2-yl)methoxy]-5-methoxybenzaldehyde Chemical compound O=CC1=CC(OC)=CC=C1OCC1=NC(C(C)(C)C)=CS1 LPDVAZUHYLUBSO-UHFFFAOYSA-N 0.000 description 1
- ZDQQEAKXIZQVAW-UHFFFAOYSA-N 2-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]acetonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CC#N)C=C3C=2)=N1 ZDQQEAKXIZQVAW-UHFFFAOYSA-N 0.000 description 1
- XXHQURQANNZXDO-UHFFFAOYSA-N 2-[2-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]ethyl]benzoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CCC=4C(=CC=CC=4)C(O)=O)C=C3C=2)=N1 XXHQURQANNZXDO-UHFFFAOYSA-N 0.000 description 1
- DULKGUCALJFHAZ-UHFFFAOYSA-N 2-[2-[[2-(4,5,6,7-tetrahydro-1,3-benzothiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=4CCCCC=4N=3)C2=C1 DULKGUCALJFHAZ-UHFFFAOYSA-N 0.000 description 1
- MTZBSMGTNXWYJX-UHFFFAOYSA-N 2-[2-[[2-(4-cyclobutyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C3CCC3)C2=C1 MTZBSMGTNXWYJX-UHFFFAOYSA-N 0.000 description 1
- LEEVCCMHYCGJFV-UHFFFAOYSA-N 2-[2-[[2-(4-cyclopropyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C3CC3)C2=C1 LEEVCCMHYCGJFV-UHFFFAOYSA-N 0.000 description 1
- NFNQYXPFZIPDRZ-UHFFFAOYSA-N 2-[2-[[2-(4-hexyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CCCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 NFNQYXPFZIPDRZ-UHFFFAOYSA-N 0.000 description 1
- QAHKMMKEIZUPHD-UHFFFAOYSA-N 2-[2-[[2-(4-methyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 QAHKMMKEIZUPHD-UHFFFAOYSA-N 0.000 description 1
- ZSDIPSKDSOEGME-UHFFFAOYSA-N 2-[2-[[2-(4-pentyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 ZSDIPSKDSOEGME-UHFFFAOYSA-N 0.000 description 1
- XITNFTYFRHDTLZ-UHFFFAOYSA-N 2-[2-[[2-(4-phenyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3C=CC=CC=3)C2=C1 XITNFTYFRHDTLZ-UHFFFAOYSA-N 0.000 description 1
- HVPOEHISSYCOEH-UHFFFAOYSA-N 2-[2-[[2-(4-propan-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CC(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 HVPOEHISSYCOEH-UHFFFAOYSA-N 0.000 description 1
- UTHUKQQIZOXCFR-UHFFFAOYSA-N 2-[2-[[2-(4-pyridin-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3N=CC=CC=3)C2=C1 UTHUKQQIZOXCFR-UHFFFAOYSA-N 0.000 description 1
- YTDHBKDNLJZAMY-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methoxy]phenyl]acetonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(COC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 YTDHBKDNLJZAMY-UHFFFAOYSA-N 0.000 description 1
- WYXJIHDNODKHJB-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methylsulfanyl]phenyl]acetonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CSC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 WYXJIHDNODKHJB-UHFFFAOYSA-N 0.000 description 1
- DNICZTISZUSBAD-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]-n-(2-methylphenyl)sulfonylacetamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NC(=O)CC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 DNICZTISZUSBAD-UHFFFAOYSA-N 0.000 description 1
- AGKCMFIHQFHQPK-UHFFFAOYSA-N 2-[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzothiophen-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CC(C)(C)C1=CSC(C=2SC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 AGKCMFIHQFHQPK-UHFFFAOYSA-N 0.000 description 1
- BDIOZPCAVUHWHS-UHFFFAOYSA-N 2-[2-[[2-(4-thiophen-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3SC=CC=3)C2=C1 BDIOZPCAVUHWHS-UHFFFAOYSA-N 0.000 description 1
- XOENEGMPYVTFJX-UHFFFAOYSA-N 2-[2-[[2-(5-propan-2-yl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound S1C(C(C)C)=CN=C1C1=CC2=CC(OCC=3C(=CC=CC=3)CC#N)=CC=C2O1 XOENEGMPYVTFJX-UHFFFAOYSA-N 0.000 description 1
- NEWJHVFYVNWCQD-UHFFFAOYSA-N 2-[2-[[2-(8-acetyl-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepin-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N=1C=2C(C(=O)C)CCCNC=2SC=1C(OC1=CC=2)=CC1=CC=2OCC1=CC=CC=C1CC#N NEWJHVFYVNWCQD-UHFFFAOYSA-N 0.000 description 1
- ROZUZHKAGVUYBL-UHFFFAOYSA-N 2-[2-[[2-[4-(1-adamantyl)-1,3-thiazol-2-yl]-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound N#CCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C34CC5CC(CC(C5)C3)C4)C2=C1 ROZUZHKAGVUYBL-UHFFFAOYSA-N 0.000 description 1
- OYNLUUAGGAATLV-UHFFFAOYSA-N 2-[2-[[2-[4-(2,2-dimethylpropyl)-1,3-thiazol-2-yl]-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound CC(C)(C)CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 OYNLUUAGGAATLV-UHFFFAOYSA-N 0.000 description 1
- PHKMPHODSDUBSZ-UHFFFAOYSA-N 2-[2-[[2-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1-benzofuran-5-yl]oxymethyl]phenyl]acetonitrile Chemical compound FC(F)(F)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 PHKMPHODSDUBSZ-UHFFFAOYSA-N 0.000 description 1
- SFRLBXJPVQADEU-UHFFFAOYSA-N 2-[4-(1-adamantyl)-1,3-thiazol-2-yl]-1-benzofuran-5-ol Chemical compound C1C(C2)CC(C3)CC2CC13C1=CSC(C=2OC3=CC=C(C=C3C=2)O)=N1 SFRLBXJPVQADEU-UHFFFAOYSA-N 0.000 description 1
- MUSNGRVILXZYGS-UHFFFAOYSA-N 2-[4-(2,2-dimethylpropyl)-1,3-thiazol-2-yl]-1-benzofuran-5-ol Chemical compound CC(C)(C)CC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 MUSNGRVILXZYGS-UHFFFAOYSA-N 0.000 description 1
- AUYLWBDILMAZNW-UHFFFAOYSA-N 2-[4-(trifluoromethyl)-1,3-thiazol-2-yl]-1-benzofuran-5-ol Chemical compound C=1C2=CC(O)=CC=C2OC=1C1=NC(C(F)(F)F)=CS1 AUYLWBDILMAZNW-UHFFFAOYSA-N 0.000 description 1
- MFENBUASWIXCPU-UHFFFAOYSA-N 2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4,5,6,7-tetrahydro-1,3-benzothiazole Chemical compound C=1C=C2OC(C=3SC=4CCCCC=4N=3)=CC2=CC=1OCC1=CC=CC=C1CC=1N=NNN=1 MFENBUASWIXCPU-UHFFFAOYSA-N 0.000 description 1
- XMJBFDFESYAMIZ-UHFFFAOYSA-N 2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-(trifluoromethyl)-1,3-thiazole Chemical compound FC(F)(F)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC4=NNN=N4)C=C3C=2)=N1 XMJBFDFESYAMIZ-UHFFFAOYSA-N 0.000 description 1
- RPPNUMDRYCDHRE-UHFFFAOYSA-N 2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-thiophen-2-yl-1,3-thiazole Chemical compound C=1C=CC=C(CC2=NNN=N2)C=1COC(C=C1C=2)=CC=C1OC=2C(SC=1)=NC=1C1=CC=CS1 RPPNUMDRYCDHRE-UHFFFAOYSA-N 0.000 description 1
- MKZCWLRQWBHPQK-UHFFFAOYSA-N 2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-5,6,7,8-tetrahydro-4h-[1,3]thiazolo[5,4-b]azepine Chemical compound C=1C=C2OC(C=3SC=4NCCCCC=4N=3)=CC2=CC=1OCC1=CC=CC=C1CC1=NN=NN1 MKZCWLRQWBHPQK-UHFFFAOYSA-N 0.000 description 1
- VLOIKVRFEHXODW-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4,5,6,7-tetrahydro-1,3-benzothiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=4CCCCC=4N=3)C2=C1 VLOIKVRFEHXODW-UHFFFAOYSA-N 0.000 description 1
- YLEBKDUVODBXHW-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-(2,2-dimethylpropyl)-1,3-thiazole Chemical compound CC(C)(C)CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 YLEBKDUVODBXHW-UHFFFAOYSA-N 0.000 description 1
- ZJEKELSVWBZQRE-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-(trifluoromethyl)-1,3-thiazole Chemical compound FC(F)(F)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 ZJEKELSVWBZQRE-UHFFFAOYSA-N 0.000 description 1
- FMWHEZKQDMGMJY-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-cyclobutyl-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C3CCC3)C2=C1 FMWHEZKQDMGMJY-UHFFFAOYSA-N 0.000 description 1
- ALRKMCTWXSDYFA-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-cyclopropyl-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C3CC3)C2=C1 ALRKMCTWXSDYFA-UHFFFAOYSA-N 0.000 description 1
- FDRMJBMVWFYVFY-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-methyl-1,3-thiazole Chemical compound CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 FDRMJBMVWFYVFY-UHFFFAOYSA-N 0.000 description 1
- VAGYUNPKHPHURY-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-pentyl-1,3-thiazole Chemical compound CCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 VAGYUNPKHPHURY-UHFFFAOYSA-N 0.000 description 1
- IUIWHLWMTFSOIL-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-phenyl-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3C=CC=CC=3)C2=C1 IUIWHLWMTFSOIL-UHFFFAOYSA-N 0.000 description 1
- LLLTXEQOJOSUOU-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-propan-2-yl-1,3-thiazole Chemical compound CC(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 LLLTXEQOJOSUOU-UHFFFAOYSA-N 0.000 description 1
- PHJAOOYXXZDHRX-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-pyridin-2-yl-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3N=CC=CC=3)C2=C1 PHJAOOYXXZDHRX-UHFFFAOYSA-N 0.000 description 1
- VGWTXHSYHFEFMY-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-4-thiophen-2-yl-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C=3SC=CC=3)C2=C1 VGWTXHSYHFEFMY-UHFFFAOYSA-N 0.000 description 1
- CFAUDFRGAMRUCE-UHFFFAOYSA-N 2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-5-propan-2-yl-1,3-thiazole Chemical compound S1C(C(C)C)=CN=C1C1=CC2=CC(OCC=3C(=CC=CC=3)CCl)=CC=C2O1 CFAUDFRGAMRUCE-UHFFFAOYSA-N 0.000 description 1
- DIQUWLCXEKOMIN-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methoxy]benzaldehyde Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(COC=4C(=CC=CC=4)C=O)C=C3C=2)=N1 DIQUWLCXEKOMIN-UHFFFAOYSA-N 0.000 description 1
- WSGCMWDSIBXWCB-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methyl]propanedioic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CC(C(O)=O)C(O)=O)C=C3C=2)=N1 WSGCMWDSIBXWCB-UHFFFAOYSA-N 0.000 description 1
- ISPSNKHMITUDOI-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]methylsulfanyl]-n-(2-methylphenyl)sulfonylbenzamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NC(=O)C1=CC=CC=C1SCC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 ISPSNKHMITUDOI-UHFFFAOYSA-N 0.000 description 1
- FXZQOBWUDTXSRK-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]-n-(2-methylphenyl)sulfonylbenzamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NC(=O)C1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 FXZQOBWUDTXSRK-UHFFFAOYSA-N 0.000 description 1
- CDNSWXWETQLGKR-UHFFFAOYSA-N 2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)C(O)=O)C=C3C=2)=N1 CDNSWXWETQLGKR-UHFFFAOYSA-N 0.000 description 1
- BOWUOGIPSRVRSJ-UHFFFAOYSA-N 2-aminohexano-6-lactam Chemical compound NC1CCCCNC1=O BOWUOGIPSRVRSJ-UHFFFAOYSA-N 0.000 description 1
- JSCFKVXPOWVVGS-UHFFFAOYSA-N 2-bromo-1-(5-methoxy-1-benzofuran-2-yl)ethanone Chemical compound COC1=CC=C2OC(C(=O)CBr)=CC2=C1 JSCFKVXPOWVVGS-UHFFFAOYSA-N 0.000 description 1
- MPNXSZJPSVBLHP-UHFFFAOYSA-N 2-chloro-n-phenylpyridine-3-carboxamide Chemical compound ClC1=NC=CC=C1C(=O)NC1=CC=CC=C1 MPNXSZJPSVBLHP-UHFFFAOYSA-N 0.000 description 1
- NMBWXBWFDHVLGS-UHFFFAOYSA-N 2-ethylbenzenesulfonamide Chemical compound CCC1=CC=CC=C1S(N)(=O)=O NMBWXBWFDHVLGS-UHFFFAOYSA-N 0.000 description 1
- CFMZSMGAMPBRBE-UHFFFAOYSA-N 2-hydroxyisoindole-1,3-dione Chemical compound C1=CC=C2C(=O)N(O)C(=O)C2=C1 CFMZSMGAMPBRBE-UHFFFAOYSA-N 0.000 description 1
- LBLYYCQCTBFVLH-UHFFFAOYSA-M 2-methylbenzenesulfonate Chemical compound CC1=CC=CC=C1S([O-])(=O)=O LBLYYCQCTBFVLH-UHFFFAOYSA-M 0.000 description 1
- HDECRAPHCDXMIJ-UHFFFAOYSA-N 2-methylbenzenesulfonyl chloride Chemical compound CC1=CC=CC=C1S(Cl)(=O)=O HDECRAPHCDXMIJ-UHFFFAOYSA-N 0.000 description 1
- YOETUEMZNOLGDB-UHFFFAOYSA-N 2-methylpropyl carbonochloridate Chemical compound CC(C)COC(Cl)=O YOETUEMZNOLGDB-UHFFFAOYSA-N 0.000 description 1
- GYXHHICIFZSKKZ-UHFFFAOYSA-N 2-sulfanylacetamide Chemical compound NC(=O)CS GYXHHICIFZSKKZ-UHFFFAOYSA-N 0.000 description 1
- CFPHMAVQAJGVPV-UHFFFAOYSA-N 2-sulfanylbutanoic acid Chemical compound CCC(S)C(O)=O CFPHMAVQAJGVPV-UHFFFAOYSA-N 0.000 description 1
- IMGGANUNCHXAQF-UHFFFAOYSA-N 2-sulfanylpentanoic acid Chemical compound CCCC(S)C(O)=O IMGGANUNCHXAQF-UHFFFAOYSA-N 0.000 description 1
- YDBVCFUMMUNSRW-UHFFFAOYSA-N 2-sulfanylpropanamide Chemical compound CC(S)C(N)=O YDBVCFUMMUNSRW-UHFFFAOYSA-N 0.000 description 1
- DQQJQXPICVLDKK-UHFFFAOYSA-N 2-tert-butyl-4-(5-methoxy-1-benzofuran-2-yl)-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C1=CSC(C(C)(C)C)=N1 DQQJQXPICVLDKK-UHFFFAOYSA-N 0.000 description 1
- QMVDZJSRSCLXSZ-UHFFFAOYSA-N 2-tert-butyl-4-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound S1C(C(C)(C)C)=NC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=C1 QMVDZJSRSCLXSZ-UHFFFAOYSA-N 0.000 description 1
- GOQLAWRYFURNHJ-UHFFFAOYSA-N 2-tert-butyl-4-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound S1C(C(C)(C)C)=NC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=C1 GOQLAWRYFURNHJ-UHFFFAOYSA-N 0.000 description 1
- CVKOOKPNCVYHNY-UHFFFAOYSA-N 3-(bromomethyl)benzonitrile Chemical compound BrCC1=CC=CC(C#N)=C1 CVKOOKPNCVYHNY-UHFFFAOYSA-N 0.000 description 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 description 1
- GAQFEBOLCZZIFK-UHFFFAOYSA-N 3-[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]propanoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CCC(O)=O)C=C3C=2)=N1 GAQFEBOLCZZIFK-UHFFFAOYSA-N 0.000 description 1
- KINYANRSNLTINQ-UHFFFAOYSA-N 3-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]-n-(2-methylphenyl)sulfonylbenzamide Chemical compound CC1=CC=CC=C1S(=O)(=O)NC(=O)C1=CC=CC(COC=2C=C3C=C(OC3=CC=2)C=2SC=C(N=2)C(C)(C)C)=C1 KINYANRSNLTINQ-UHFFFAOYSA-N 0.000 description 1
- QEMAXXDNCFWUMS-UHFFFAOYSA-N 3-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzoic acid Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C=C(C=CC=4)C(O)=O)C=C3C=2)=N1 QEMAXXDNCFWUMS-UHFFFAOYSA-N 0.000 description 1
- NPVFUQSGOYOOHP-UHFFFAOYSA-N 3-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzonitrile Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C=C(C=CC=4)C#N)C=C3C=2)=N1 NPVFUQSGOYOOHP-UHFFFAOYSA-N 0.000 description 1
- DKIDEFUBRARXTE-UHFFFAOYSA-N 3-mercaptopropanoic acid Chemical compound OC(=O)CCS DKIDEFUBRARXTE-UHFFFAOYSA-N 0.000 description 1
- JNJXNTYEINIXPS-UHFFFAOYSA-N 4-(1-adamantyl)-2-(5-methoxy-1-benzofuran-2-yl)-1,3-thiazole Chemical compound C1C(C2)CC(C3)CC2CC13C1=CSC(C=2OC3=CC=C(C=C3C=2)OC)=N1 JNJXNTYEINIXPS-UHFFFAOYSA-N 0.000 description 1
- USAGAUXLVIAUFA-UHFFFAOYSA-N 4-(1-adamantyl)-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole;hydrochloride Chemical compound Cl.C=1C=C2OC(C=3SC=C(N=3)C34CC5CC(CC(C5)C3)C4)=CC2=CC=1OCC1=CC=CC=C1CC=1N=NNN=1 USAGAUXLVIAUFA-UHFFFAOYSA-N 0.000 description 1
- KNFVGADUTWXZLL-UHFFFAOYSA-N 4-(1-adamantyl)-2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound ClCC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C34CC5CC(CC(C5)C3)C4)C2=C1 KNFVGADUTWXZLL-UHFFFAOYSA-N 0.000 description 1
- NNKPGIWIUSVXIT-UHFFFAOYSA-N 4-(2,2-dimethylpropyl)-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=N1 NNKPGIWIUSVXIT-UHFFFAOYSA-N 0.000 description 1
- JHKIUPOLQADFGQ-UHFFFAOYSA-N 4-cyclobutyl-2-(5-methoxy-1-benzofuran-2-yl)-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2OC=1C(SC=1)=NC=1C1CCC1 JHKIUPOLQADFGQ-UHFFFAOYSA-N 0.000 description 1
- FVVUOJUWJCSVED-UHFFFAOYSA-N 4-cyclobutyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound C=1C=CC=C(CC=2NN=NN=2)C=1COC(C=C1C=2)=CC=C1OC=2C(SC=1)=NC=1C1CCC1 FVVUOJUWJCSVED-UHFFFAOYSA-N 0.000 description 1
- XWFZIAPOIZCUOR-UHFFFAOYSA-N 4-cyclopropyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound C=1C=CC=C(CC=2NN=NN=2)C=1COC(C=C1C=2)=CC=C1OC=2C(SC=1)=NC=1C1CC1 XWFZIAPOIZCUOR-UHFFFAOYSA-N 0.000 description 1
- SANAIMQSTRMYGD-UHFFFAOYSA-N 4-hexyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CCCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC4=NNN=N4)C=C3C=2)=N1 SANAIMQSTRMYGD-UHFFFAOYSA-N 0.000 description 1
- UQRONKZLYKUEMO-UHFFFAOYSA-N 4-methyl-1-(2,4,6-trimethylphenyl)pent-4-en-2-one Chemical group CC(=C)CC(=O)Cc1c(C)cc(C)cc1C UQRONKZLYKUEMO-UHFFFAOYSA-N 0.000 description 1
- HSYSADQZVDOHMN-UHFFFAOYSA-N 4-methyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC4=NNN=N4)C=C3C=2)=N1 HSYSADQZVDOHMN-UHFFFAOYSA-N 0.000 description 1
- DDODANZBNHLARU-UHFFFAOYSA-N 4-pentyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CCCCCC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC4=NNN=N4)C=C3C=2)=N1 DDODANZBNHLARU-UHFFFAOYSA-N 0.000 description 1
- KURJDTNKVWCTII-UHFFFAOYSA-N 4-phenyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound C=1C=CC=C(CC2=NNN=N2)C=1COC(C=C1C=2)=CC=C1OC=2C(SC=1)=NC=1C1=CC=CC=C1 KURJDTNKVWCTII-UHFFFAOYSA-N 0.000 description 1
- XBZYDWCIBOPVHJ-UHFFFAOYSA-N 4-propan-2-yl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)C1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=N1 XBZYDWCIBOPVHJ-UHFFFAOYSA-N 0.000 description 1
- DNFXYJIENXCYEU-UHFFFAOYSA-N 4-pyridin-2-yl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole;hydrochloride Chemical compound Cl.C=1C=CC=C(CC=2NN=NN=2)C=1COC(C=C1C=2)=CC=C1OC=2C(SC=1)=NC=1C1=CC=CC=N1 DNFXYJIENXCYEU-UHFFFAOYSA-N 0.000 description 1
- ZJIQUYZWMIXTRM-UHFFFAOYSA-N 4-tert-butyl-2-(5-methoxy-1-benzothiophen-2-yl)-1,3-thiazole Chemical compound C=1C2=CC(OC)=CC=C2SC=1C1=NC(C(C)(C)C)=CS1 ZJIQUYZWMIXTRM-UHFFFAOYSA-N 0.000 description 1
- RDKNZTPFGVOMAI-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenoxy]methyl]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(COC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=N1 RDKNZTPFGVOMAI-UHFFFAOYSA-N 0.000 description 1
- YZIWSKJQONADSN-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzothiophen-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2SC3=CC=C(OCC=4C(=CC=CC=4)CC4=NNN=N4)C=C3C=2)=N1 YZIWSKJQONADSN-UHFFFAOYSA-N 0.000 description 1
- UXEPBOSUTKINCT-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]sulfanylmethyl]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CSC=4C(=CC=CC=4)CC=4NN=NN=4)C=C3C=2)=N1 UXEPBOSUTKINCT-UHFFFAOYSA-N 0.000 description 1
- SZUFOPUHQJEOMC-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(chloromethyl)phenoxy]methyl]-1-benzofuran-2-yl]-1,3-thiazole Chemical class CC(C)(C)C1=CSC(C=2OC3=CC=C(COC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 SZUFOPUHQJEOMC-UHFFFAOYSA-N 0.000 description 1
- JPBYSHRCPHZBBS-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzothiophen-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2SC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 JPBYSHRCPHZBBS-UHFFFAOYSA-N 0.000 description 1
- XVLHZWGKLQAOCX-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[2-(chloromethyl)phenyl]sulfanylmethyl]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(CSC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 XVLHZWGKLQAOCX-UHFFFAOYSA-N 0.000 description 1
- QGJRBLUNOCMWJT-UHFFFAOYSA-N 4-tert-butyl-2-[5-[[3-(2h-tetrazol-5-yl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound CC(C)(C)C1=CSC(C=2OC3=CC=C(OCC=4C=C(C=CC=4)C4=NNN=N4)C=C3C=2)=N1 QGJRBLUNOCMWJT-UHFFFAOYSA-N 0.000 description 1
- VAPRPGOSGWMTJK-UHFFFAOYSA-N 5-methoxy-1-benzofuran-2-carbonyl chloride Chemical compound COC1=CC=C2OC(C(Cl)=O)=CC2=C1 VAPRPGOSGWMTJK-UHFFFAOYSA-N 0.000 description 1
- GKOBIPBVHLFDES-UHFFFAOYSA-N 5-methoxy-2-[(4-phenyl-1,3-thiazol-2-yl)methoxy]benzaldehyde Chemical compound O=CC1=CC(OC)=CC=C1OCC1=NC(C=2C=CC=CC=2)=CS1 GKOBIPBVHLFDES-UHFFFAOYSA-N 0.000 description 1
- ZMKJSTWSUYKRHU-UHFFFAOYSA-N 5-propan-2-yl-2-[5-[[2-(2h-tetrazol-5-ylmethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazole Chemical compound S1C(C(C)C)=CN=C1C1=CC2=CC(OCC=3C(=CC=CC=3)CC=3NN=NN=3)=CC=C2O1 ZMKJSTWSUYKRHU-UHFFFAOYSA-N 0.000 description 1
- TZCYLJGNWDVJRA-UHFFFAOYSA-N 6-chloro-1-hydroxybenzotriazole Chemical compound C1=C(Cl)C=C2N(O)N=NC2=C1 TZCYLJGNWDVJRA-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- KLSJWNVTNUYHDU-UHFFFAOYSA-N Amitrole Chemical compound NC1=NC=NN1 KLSJWNVTNUYHDU-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- GEHMBYLTCISYNY-UHFFFAOYSA-N Ammonium sulfamate Chemical compound [NH4+].NS([O-])(=O)=O GEHMBYLTCISYNY-UHFFFAOYSA-N 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 229910015900 BF3 Inorganic materials 0.000 description 1
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RENMDAKOXSCIGH-UHFFFAOYSA-N Chloroacetonitrile Chemical compound ClCC#N RENMDAKOXSCIGH-UHFFFAOYSA-N 0.000 description 1
- 229910021555 Chromium Chloride Inorganic materials 0.000 description 1
- 229910021590 Copper(II) bromide Inorganic materials 0.000 description 1
- XFXPMWWXUTWYJX-UHFFFAOYSA-N Cyanide Chemical compound N#[C-] XFXPMWWXUTWYJX-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- ASMQGLCHMVWBQR-UHFFFAOYSA-N Diphenyl phosphate Chemical compound C=1C=CC=CC=1OP(=O)(O)OC1=CC=CC=C1 ASMQGLCHMVWBQR-UHFFFAOYSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- PHSPJQZRQAJPPF-UHFFFAOYSA-N N-alpha-Methylhistamine Chemical compound CNCCC1=CN=CN1 PHSPJQZRQAJPPF-UHFFFAOYSA-N 0.000 description 1
- XNPOFXIBHOVFFH-UHFFFAOYSA-N N-cyclohexyl-N'-(2-(4-morpholinyl)ethyl)carbodiimide Chemical compound C1CCCCC1N=C=NCCN1CCOCC1 XNPOFXIBHOVFFH-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- QOSMNYMQXIVWKY-UHFFFAOYSA-N Propyl levulinate Chemical compound CCCOC(=O)CCC(C)=O QOSMNYMQXIVWKY-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-M Trifluoroacetate Chemical compound [O-]C(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-M 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 1
- 239000012346 acetyl chloride Substances 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 229910000287 alkaline earth metal oxide Inorganic materials 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- SMZOGRDCAXLAAR-UHFFFAOYSA-N aluminium isopropoxide Chemical compound [Al+3].CC(C)[O-].CC(C)[O-].CC(C)[O-] SMZOGRDCAXLAAR-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- YDPLDMLRERBXAV-UHFFFAOYSA-N aluminum;triazide Chemical compound [Al+3].[N-]=[N+]=[N-].[N-]=[N+]=[N-].[N-]=[N+]=[N-] YDPLDMLRERBXAV-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229950003476 aminothiazole Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- SWLVFNYSXGMGBS-UHFFFAOYSA-N ammonium bromide Chemical compound [NH4+].[Br-] SWLVFNYSXGMGBS-UHFFFAOYSA-N 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 1
- 150000007860 aryl ester derivatives Chemical class 0.000 description 1
- 150000001540 azides Chemical class 0.000 description 1
- 229940077388 benzenesulfonate Drugs 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-M benzenesulfonate Chemical compound [O-]S(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-M 0.000 description 1
- CSKNSYBAZOQPLR-UHFFFAOYSA-N benzenesulfonyl chloride Chemical compound ClS(=O)(=O)C1=CC=CC=C1 CSKNSYBAZOQPLR-UHFFFAOYSA-N 0.000 description 1
- 229910052796 boron Inorganic materials 0.000 description 1
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 1
- 125000005569 butenylene group Chemical group 0.000 description 1
- 125000004106 butoxy group Chemical group [*]OC([H])([H])C([H])([H])C(C([H])([H])[H])([H])[H] 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004063 butyryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- UETLMBWMVIQIGU-UHFFFAOYSA-N calcium azide Chemical compound [Ca+2].[N-]=[N+]=[N-].[N-]=[N+]=[N-] UETLMBWMVIQIGU-UHFFFAOYSA-N 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 1
- QSWDMMVNRMROPK-UHFFFAOYSA-K chromium(3+) trichloride Chemical compound [Cl-].[Cl-].[Cl-].[Cr+3] QSWDMMVNRMROPK-UHFFFAOYSA-K 0.000 description 1
- WYYQVWLEPYFFLP-UHFFFAOYSA-K chromium(3+);triacetate Chemical compound [Cr+3].CC([O-])=O.CC([O-])=O.CC([O-])=O WYYQVWLEPYFFLP-UHFFFAOYSA-K 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- DOBRDRYODQBAMW-UHFFFAOYSA-N copper(i) cyanide Chemical compound [Cu+].N#[C-] DOBRDRYODQBAMW-UHFFFAOYSA-N 0.000 description 1
- 125000002592 cumenyl group Chemical group C1(=C(C=CC=C1)*)C(C)C 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000005947 deacylation reaction Methods 0.000 description 1
- BXCVCLILGBBCBR-UHFFFAOYSA-N diethyl 2-[[2-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]phenyl]methyl]propanedioate Chemical compound CCOC(=O)C(C(=O)OCC)CC1=CC=CC=C1COC1=CC=C(OC(=C2)C=3SC=C(N=3)C(C)(C)C)C2=C1 BXCVCLILGBBCBR-UHFFFAOYSA-N 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- RDEWTAHSEKSPPT-UHFFFAOYSA-N ethyl 2-(bromomethyl)benzoate Chemical compound CCOC(=O)C1=CC=CC=C1CBr RDEWTAHSEKSPPT-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- PVBRSNZAOAJRKO-UHFFFAOYSA-N ethyl 2-sulfanylacetate Chemical compound CCOC(=O)CS PVBRSNZAOAJRKO-UHFFFAOYSA-N 0.000 description 1
- MVEAAGBEUOMFRX-UHFFFAOYSA-N ethyl acetate;hydrochloride Chemical compound Cl.CCOC(C)=O MVEAAGBEUOMFRX-UHFFFAOYSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- LIWAQLJGPBVORC-UHFFFAOYSA-N ethylmethylamine Chemical compound CCNC LIWAQLJGPBVORC-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000006038 hexenyl group Chemical group 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- JUINSXZKUKVTMD-UHFFFAOYSA-N hydrogen azide Chemical compound N=[N+]=[N-] JUINSXZKUKVTMD-UHFFFAOYSA-N 0.000 description 1
- 229910003480 inorganic solid Inorganic materials 0.000 description 1
- 229910000765 intermetallic Inorganic materials 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 1
- CFHGBZLNZZVTAY-UHFFFAOYSA-N lawesson's reagent Chemical compound C1=CC(OC)=CC=C1P1(=S)SP(=S)(C=2C=CC(OC)=CC=2)S1 CFHGBZLNZZVTAY-UHFFFAOYSA-N 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- YEESKJGWJFYOOK-IJHYULJSSA-N leukotriene D4 Chemical compound CCCCC\C=C/C\C=C/C=C/C=C/[C@H]([C@@H](O)CCCC(O)=O)SC[C@H](N)C(=O)NCC(O)=O YEESKJGWJFYOOK-IJHYULJSSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- NXPHGHWWQRMDIA-UHFFFAOYSA-M magnesium;carbanide;bromide Chemical compound [CH3-].[Mg+2].[Br-] NXPHGHWWQRMDIA-UHFFFAOYSA-M 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- ITYJDNHFRZSTJY-UHFFFAOYSA-N methanesulfonyl bromide Chemical compound CS(Br)(=O)=O ITYJDNHFRZSTJY-UHFFFAOYSA-N 0.000 description 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 1
- MKIJJIMOAABWGF-UHFFFAOYSA-N methyl 2-sulfanylacetate Chemical compound COC(=O)CS MKIJJIMOAABWGF-UHFFFAOYSA-N 0.000 description 1
- SNWKNPMDQONHKK-UHFFFAOYSA-N methyl 2-sulfanylpropanoate Chemical compound COC(=O)C(C)S SNWKNPMDQONHKK-UHFFFAOYSA-N 0.000 description 1
- OESMCLIZLYTGJJ-UHFFFAOYSA-N methyl 3-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]oxymethyl]benzoate Chemical compound COC(=O)C1=CC=CC(COC=2C=C3C=C(OC3=CC=2)C=2SC=C(N=2)C(C)(C)C)=C1 OESMCLIZLYTGJJ-UHFFFAOYSA-N 0.000 description 1
- VMIHLSLVBTVFHN-UHFFFAOYSA-N methyl 4-[[2-(4-tert-butyl-1,3-thiazol-2-yl)-1-benzofuran-5-yl]-(4-methoxy-4-oxobutyl)sulfanylmethyl]sulfanylbutanoate Chemical compound C=1C2=CC(C(SCCCC(=O)OC)SCCCC(=O)OC)=CC=C2OC=1C1=NC(C(C)(C)C)=CS1 VMIHLSLVBTVFHN-UHFFFAOYSA-N 0.000 description 1
- YRIAPEVGKLRGHX-UHFFFAOYSA-N methyl 4-sulfanylbutanoate Chemical compound COC(=O)CCCS YRIAPEVGKLRGHX-UHFFFAOYSA-N 0.000 description 1
- LNOPIUAQISRISI-UHFFFAOYSA-N n'-hydroxy-2-propan-2-ylsulfonylethanimidamide Chemical compound CC(C)S(=O)(=O)CC(N)=NO LNOPIUAQISRISI-UHFFFAOYSA-N 0.000 description 1
- UXBJXJHRVOEYPA-UHFFFAOYSA-N n,n-dimethyl-3-sulfanylpropanamide Chemical compound CN(C)C(=O)CCS UXBJXJHRVOEYPA-UHFFFAOYSA-N 0.000 description 1
- VMESOKCXSYNAKD-UHFFFAOYSA-N n,n-dimethylhydroxylamine Chemical compound CN(C)O VMESOKCXSYNAKD-UHFFFAOYSA-N 0.000 description 1
- PXSXRABJBXYMFT-UHFFFAOYSA-N n-hexylhexan-1-amine Chemical compound CCCCCCNCCCCCC PXSXRABJBXYMFT-UHFFFAOYSA-N 0.000 description 1
- JACMPVXHEARCBO-UHFFFAOYSA-N n-pentylpentan-1-amine Chemical compound CCCCCNCCCCC JACMPVXHEARCBO-UHFFFAOYSA-N 0.000 description 1
- QLVFXBSHXBMJMU-UHFFFAOYSA-N n-tert-butyl-n-[[2-(5-hydroxy-1-benzofuran-2-yl)-1,3-thiazol-4-yl]methyl]acetamide Chemical compound CC(=O)N(C(C)(C)C)CC1=CSC(C=2OC3=CC=C(O)C=C3C=2)=N1 QLVFXBSHXBMJMU-UHFFFAOYSA-N 0.000 description 1
- WYLAJBGOOAKMAP-UHFFFAOYSA-N n-tert-butyl-n-[[2-[5-[[2-(chloromethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazol-4-yl]methyl]acetamide Chemical compound CC(=O)N(C(C)(C)C)CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CCl)C=C3C=2)=N1 WYLAJBGOOAKMAP-UHFFFAOYSA-N 0.000 description 1
- YWORNCVWQMGRQA-UHFFFAOYSA-N n-tert-butyl-n-[[2-[5-[[2-(cyanomethyl)phenyl]methoxy]-1-benzofuran-2-yl]-1,3-thiazol-4-yl]methyl]acetamide Chemical compound CC(=O)N(C(C)(C)C)CC1=CSC(C=2OC3=CC=C(OCC=4C(=CC=CC=4)CC#N)C=C3C=2)=N1 YWORNCVWQMGRQA-UHFFFAOYSA-N 0.000 description 1
- ZFIFHAKCBWOSRN-UHFFFAOYSA-N naphthalene-1-sulfonamide Chemical compound C1=CC=C2C(S(=O)(=O)N)=CC=CC2=C1 ZFIFHAKCBWOSRN-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000012299 nitrogen atmosphere Substances 0.000 description 1
- LYGJENNIWJXYER-UHFFFAOYSA-N nitromethane Chemical compound C[N+]([O-])=O LYGJENNIWJXYER-UHFFFAOYSA-N 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N octane Chemical compound CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 229940100684 pentylamine Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- OAHKWDDSKCRNFE-UHFFFAOYSA-N phenylmethanesulfonyl chloride Chemical compound ClS(=O)(=O)CC1=CC=CC=C1 OAHKWDDSKCRNFE-UHFFFAOYSA-N 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-N phosphoric acid Substances OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 150000003018 phosphorus compounds Chemical class 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- TZLVRPLSVNESQC-UHFFFAOYSA-N potassium azide Chemical compound [K+].[N-]=[N+]=[N-] TZLVRPLSVNESQC-UHFFFAOYSA-N 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 1
- 125000001501 propionyl group Chemical group O=C([*])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000159 protein binding assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011946 reduction process Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- ODZPKZBBUMBTMG-UHFFFAOYSA-N sodium amide Chemical compound [NH2-].[Na+] ODZPKZBBUMBTMG-UHFFFAOYSA-N 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940095064 tartrate Drugs 0.000 description 1
- 125000006318 tert-butyl amino group Chemical group [H]N(*)C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 125000000335 thiazolyl group Chemical group 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000011135 tin Substances 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 description 1
- 125000003774 valeryl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 125000005023 xylyl group Chemical group 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919117733A GB9117733D0 (en) | 1991-08-16 | 1991-08-16 | New thiazolylbenzofuran derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same |
| GB929201057A GB9201057D0 (en) | 1992-01-17 | 1992-01-17 | New thiazolylbenzofuran derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69230163D1 DE69230163D1 (de) | 1999-11-25 |
| DE69230163T2 true DE69230163T2 (de) | 2000-03-23 |
Family
ID=26299417
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69230163T Expired - Fee Related DE69230163T2 (de) | 1991-08-16 | 1992-08-12 | Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5296495A (enFirst) |
| EP (1) | EP0528337B1 (enFirst) |
| JP (1) | JP2600644B2 (enFirst) |
| KR (1) | KR930004304A (enFirst) |
| CN (1) | CN1033088C (enFirst) |
| AT (1) | ATE185807T1 (enFirst) |
| AU (1) | AU665007B2 (enFirst) |
| CA (1) | CA2076192A1 (enFirst) |
| DE (1) | DE69230163T2 (enFirst) |
| DK (1) | DK0528337T3 (enFirst) |
| ES (1) | ES2137169T3 (enFirst) |
| GR (1) | GR3032425T3 (enFirst) |
| HU (2) | HUT64336A (enFirst) |
| MX (1) | MX9204746A (enFirst) |
| SG (1) | SG45259A1 (enFirst) |
| TW (1) | TW224464B (enFirst) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2102078A1 (en) * | 1992-11-02 | 1994-05-03 | Akira Takase | A process for producing (e)-alkoxyimino or hydroxyiminoacetamide compounds and intermediates therefor |
| KR100329887B1 (ko) * | 1992-11-02 | 2002-11-02 | 시오노기세이야쿠가부시키가이샤 | (e)-알콕시이미노-및하이드록시이미노-아세트아미드화합물의제조방법 및 그의 제조용중간체 |
| DE4425609A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | Benzofuranyl- und Benzothienyloxazolidinone |
| KR19990076788A (ko) * | 1996-01-22 | 1999-10-15 | 후지야마 아키라 | 티아졸릴벤조푸란 유도체 및 그를 함유하는 약제학적 조성물 |
| ATE257703T1 (de) * | 1997-10-27 | 2004-01-15 | Takeda Chemical Industries Ltd | 1,3-thiazole als adenosine a3 rezeptor antagonisten zur behandlung von asthma, allergien und diabetes |
| US6262066B1 (en) | 1998-07-27 | 2001-07-17 | Schering Corporation | High affinity ligands for nociceptin receptor ORL-1 |
| AU2002349705A1 (en) | 2001-12-03 | 2003-06-17 | Japan Tobacco Inc. | Azole compound and medicinal use thereof |
| US7148248B2 (en) | 2002-11-29 | 2006-12-12 | Masako Nozaki | Method of treating or inhibiting the development of brain inflammation and sepsis |
| EP1424101A3 (en) * | 2002-11-29 | 2004-08-18 | NOZAKI, Masako | Use of a leukotriene C4 and D4 receptor antagonist for the preparation of a medicament for treating or preventing brain inflammation and sepsis |
| WO2004089918A1 (ja) * | 2003-04-09 | 2004-10-21 | Japan Tobacco Inc. | 複素芳香５員環化合物及びその医薬用途 |
| JP2005008631A (ja) * | 2003-05-29 | 2005-01-13 | New Industry Research Organization | ベンゾフラン化合物、およびそれを含有してなる医薬組成物 |
| EP1627873A4 (en) | 2003-05-29 | 2007-12-05 | New Ind Res Organization | BENZOFURAN-BASED COMPOUND AND MEDICINAL COMPOSITION CONTAINING THE SAME |
| ITTO20040125A1 (it) * | 2004-03-01 | 2004-06-01 | Rotta Research Lab | Nuove amidine eterocicliche inibitrici la produzione di ossido d'azoto (no) ad attivita' antinfiammatoria ed analgesica |
| CN101022796B (zh) | 2004-07-14 | 2013-02-27 | 炎症研究中心有限公司 | 抑制肿瘤转移的方法 |
| MX2007001561A (es) * | 2004-08-04 | 2007-04-16 | Schering Corp | Formulacion farmaceutica que comprende pleconaril para tratamiento de enfermedades de vias aereas. |
| WO2006046683A1 (en) * | 2004-10-25 | 2006-05-04 | Astellas Pharma Inc. | Thiazolylbenzofuran derivatives as leukotriene and prostaglandin d2 receptor antagonists |
| US20060110449A1 (en) | 2004-10-25 | 2006-05-25 | Lorber Richard R | Pharmaceutical composition |
| JPWO2006054793A1 (ja) * | 2004-11-19 | 2008-06-05 | 財団法人新産業創造研究機構 | ベンゾフラン化合物、およびそれを含有してなる医薬組成物 |
| KR20090026217A (ko) * | 2006-07-11 | 2009-03-11 | 쉐링 코포레이션 | 치환된 5-옥사졸-2-일-퀴놀린 화합물의 크시나포에이트 염 |
| CA2669704A1 (en) * | 2006-11-16 | 2008-05-22 | Allergan, Inc. | Sulfoximines as kinase inhibitors |
| CA2764830A1 (en) | 2009-06-16 | 2010-12-23 | Schering Corporation | Novel [3,2-c] heteroaryl steroids as glucocorticoid receptor agonists, compositions and uses thereof |
| EP2723717A2 (en) | 2011-06-24 | 2014-04-30 | Amgen Inc. | Trpm8 antagonists and their use in treatments |
| AU2012272898A1 (en) | 2011-06-24 | 2013-04-11 | Amgen Inc. | TRPM8 antagonists and their use in treatments |
| ES2790358T3 (es) | 2011-12-28 | 2020-10-27 | Global Blood Therapeutics Inc | Compuestos de heteroaril aldehído sustituido y métodos para su uso en el aumento de la oxigenación tisular |
| CA3142817A1 (en) * | 2011-12-28 | 2013-07-04 | Global Blood Therapeutics, Inc. | Substituted benzaldehyde compounds and methods for their use in increasing tissue oxygenation |
| US8952009B2 (en) | 2012-08-06 | 2015-02-10 | Amgen Inc. | Chroman derivatives as TRPM8 inhibitors |
| CN112500338A (zh) | 2013-03-15 | 2021-03-16 | 全球血液疗法股份有限公司 | 化合物及其用于调节血红蛋白的用途 |
| US9802900B2 (en) | 2013-03-15 | 2017-10-31 | Global Blood Therapeutics, Inc. | Bicyclic heteroaryl compounds and uses thereof for the modulation of hemoglobin |
| US10266551B2 (en) | 2013-03-15 | 2019-04-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US8952171B2 (en) | 2013-03-15 | 2015-02-10 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EP3919056B1 (en) | 2013-03-15 | 2024-08-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9422279B2 (en) | 2013-03-15 | 2016-08-23 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EP2968299B1 (en) | 2013-03-15 | 2021-01-20 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9604999B2 (en) | 2013-03-15 | 2017-03-28 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US9458139B2 (en) | 2013-03-15 | 2016-10-04 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| US10100043B2 (en) | 2013-03-15 | 2018-10-16 | Global Blood Therapeutics, Inc. | Substituted aldehyde compounds and methods for their use in increasing tissue oxygenation |
| US20140274961A1 (en) | 2013-03-15 | 2014-09-18 | Global Blood Therapeutics, Inc. | Compounds and uses thereof for the modulation of hemoglobin |
| EA202092627A1 (ru) | 2013-11-18 | 2021-09-30 | Глобал Блад Терапьютикс, Инк. | Соединения и их применения для модуляции гемоглобина |
| SG10201911662YA (en) | 2014-02-07 | 2020-02-27 | Global Blood Therapeutics Inc | Crystalline polymorphs of the free base of 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)pyridin-3-yl)methoxy)benzaldehyde |
| DK3186233T3 (da) | 2014-08-29 | 2021-11-22 | Chdi Foundation Inc | Prober til billeddannelse af huntingtin-protein |
| MA41841A (fr) | 2015-03-30 | 2018-02-06 | Global Blood Therapeutics Inc | Composés aldéhyde pour le traitement de la fibrose pulmonaire, de l'hypoxie, et de maladies auto-immunes et des tissus conjonctifs |
| HUE072191T2 (hu) | 2015-12-04 | 2025-10-28 | Global Blood Therapeutics Inc | A 2-hidoxi-6-((2-(1-izopropil-1H-pirazol-5-il)piridin-3-il)metoxi)benzaldehid adagolási rendje |
| TWI825524B (zh) | 2016-05-12 | 2023-12-11 | 美商全球血液治療公司 | 用於合成2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)-吡啶-3-基)甲氧基)苯甲醛之方法 |
| TWI778983B (zh) | 2016-10-12 | 2022-10-01 | 美商全球血液治療公司 | 包含2-羥基-6-((2-(1-異丙基-1h-吡唑-5-基)吡啶-3-基)甲氧基)-苯甲醛之片劑 |
| WO2018115984A1 (en) | 2016-12-19 | 2018-06-28 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammation |
| US11014884B2 (en) | 2018-10-01 | 2021-05-25 | Global Blood Therapeutics, Inc. | Modulators of hemoglobin |
| TW202500134A (zh) * | 2023-05-18 | 2025-01-01 | 美商恩維達醫療公司 | G-蛋白偶聯受體之拮抗劑 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62142168A (ja) * | 1985-10-16 | 1987-06-25 | Mitsubishi Chem Ind Ltd | チアゾ−ル誘導体及びそれを有効成分とするロイコトリエンきつ抗剤 |
| US4742057A (en) * | 1985-12-05 | 1988-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Antiallergic thiazole compounds |
| US4908357A (en) * | 1986-04-30 | 1990-03-13 | Fmc Corporation | Photoactive azole pesticides |
| US5001140A (en) * | 1989-04-17 | 1991-03-19 | Hoffmann-La Roche Inc. | Cycloalkylthiazoles |
| JPH02169584A (ja) * | 1988-12-22 | 1990-06-29 | Mitsubishi Kasei Corp | ビニルチアゾール誘導体およびそれを有効成分とする薬剤 |
| US5032588A (en) * | 1989-12-08 | 1991-07-16 | Abbott Laboratories | Thiazole lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
| DE3941438A1 (de) * | 1989-12-15 | 1991-06-20 | Hoechst Ag | Neue 2-substituierte 4-(3-alkyl-5-tert.-butyl-4-hydroxy-phenyl)-thiazole, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung |
-
1992
- 1992-08-06 JP JP4210308A patent/JP2600644B2/ja not_active Expired - Fee Related
- 1992-08-12 AT AT92113705T patent/ATE185807T1/de not_active IP Right Cessation
- 1992-08-12 SG SG1996002173A patent/SG45259A1/en unknown
- 1992-08-12 DK DK92113705T patent/DK0528337T3/da active
- 1992-08-12 EP EP92113705A patent/EP0528337B1/en not_active Expired - Lifetime
- 1992-08-12 US US07/929,751 patent/US5296495A/en not_active Expired - Fee Related
- 1992-08-12 ES ES92113705T patent/ES2137169T3/es not_active Expired - Lifetime
- 1992-08-12 DE DE69230163T patent/DE69230163T2/de not_active Expired - Fee Related
- 1992-08-13 AU AU21029/92A patent/AU665007B2/en not_active Ceased
- 1992-08-14 HU HU9202656A patent/HUT64336A/hu unknown
- 1992-08-14 KR KR1019920014712A patent/KR930004304A/ko not_active Ceased
- 1992-08-14 CA CA002076192A patent/CA2076192A1/en not_active Abandoned
- 1992-08-14 TW TW081106455A patent/TW224464B/zh active
- 1992-08-15 CN CN92110877A patent/CN1033088C/zh not_active Expired - Fee Related
- 1992-08-17 MX MX9204746A patent/MX9204746A/es not_active IP Right Cessation
-
1995
- 1995-06-22 HU HU95P/P00346P patent/HU211630A9/hu unknown
-
2000
- 2000-01-19 GR GR20000400122T patent/GR3032425T3/el not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP0528337B1 (en) | 1999-10-20 |
| ES2137169T3 (es) | 1999-12-16 |
| JP2600644B2 (ja) | 1997-04-16 |
| HU211630A9 (en) | 1995-12-28 |
| SG45259A1 (en) | 1998-01-16 |
| CN1033088C (zh) | 1996-10-23 |
| KR930004304A (ko) | 1993-03-22 |
| HU9202656D0 (en) | 1992-10-28 |
| GR3032425T3 (en) | 2000-05-31 |
| MX9204746A (es) | 1994-04-29 |
| TW224464B (enFirst) | 1994-06-01 |
| DE69230163D1 (de) | 1999-11-25 |
| CA2076192A1 (en) | 1993-02-17 |
| AU665007B2 (en) | 1995-12-14 |
| JPH05202040A (ja) | 1993-08-10 |
| CN1070910A (zh) | 1993-04-14 |
| ATE185807T1 (de) | 1999-11-15 |
| AU2102992A (en) | 1993-02-18 |
| US5296495A (en) | 1994-03-22 |
| DK0528337T3 (da) | 2000-03-27 |
| EP0528337A1 (en) | 1993-02-24 |
| HUT64336A (en) | 1993-12-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69230163T2 (de) | Thiazolylbenzofuranderivate, Verfahren zu deren Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten | |
| DE69310501T2 (de) | Chinolylbenzofuran derivate als leukotrien-antagonisten | |
| DE69712042T2 (de) | Thiazolylbenzofuranderivate und pharmazeutische zusammensetzungen die sie enthalten | |
| DE69322605T2 (de) | Imidazo (1,2-a)pyridine als Bradykinin-Antagonisten | |
| US5102667A (en) | Isoindolone derivatives, their preparation and the pharmaceutical compositions containing them | |
| DE69529614T2 (de) | Heterobizyklische derivate | |
| DE69426205T2 (de) | Gastrin-und cck-rezeptorligande | |
| AU768726B2 (en) | Indole derivatives and their use for the treatment of osteoporosis amongst other applications | |
| JP2021011494A (ja) | Ｐｄｅ４抑制活性を有する化合物の製造方法 | |
| EP0001113A1 (de) | Thienothiazinderivate, deren Herstellung, sowie diese enthaltende Präparate | |
| WO1999000372A1 (fr) | Sulfamides et leur utilisation medicale | |
| CA2101521A1 (en) | 5-heteroyl indole derivatives | |
| DE69224115T2 (de) | Heteroaryl substituierte Hydroxylaminderivate als Lipoxygenase-Inhibitoren | |
| DE69125308T2 (de) | Indolderivate | |
| CN110498770B (zh) | 一种制备恶拉戈利中间体的方法 | |
| CA2356838A1 (en) | Imidazole compounds and medicinal use thereof | |
| DE69419917T2 (de) | Indazolderivate | |
| JPH04211652A (ja) | ヘキサヒドロベンズ［ｃｄ］インドール | |
| DE60223227T2 (de) | BenzoÄbÄthiophenderivate und Verfahren zu deren Herstellung | |
| JPH0378854B2 (enFirst) | ||
| JPH0673012A (ja) | ４−イミノキノリン、その製法およびその使用 | |
| HUT65252A (en) | Process for producing of quinolin-2-yl-methoxybenzylhydroxyureas and pharmaceutical compositions comprising them | |
| JPS61176563A (ja) | ４，４‐ジアルキル‐２‐アゼチジノン類の製造法 | |
| JPH08325265A (ja) | チアゾリルベンゾフラン誘導体の製造方法、および該製造方法に用いられる化合物 | |
| US3433802A (en) | 3-(n-lower-alkylanilino)pyrrolidines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |